Valuation: Convatec Group PLC

Market Cap 6.02B 5.15B 4.81B 4.41B 8.29B 576B 8.45B 57.01B 22.22B 288B 22.59B 22.09B 955B P/E 2026 *
24.2x
P/E 2027 * 16.9x
Enterprise Value 7.36B 6.3B 5.88B 5.4B 10.14B 704B 10.34B 69.76B 27.19B 353B 27.64B 27.04B 1,169B EV / Sales 2026 *
2.88x
EV / Sales 2027 * 2.62x
Free-Float
95.17%
Yield 2026 *
2.57%
Yield 2027 * 2.92%
1 day-2.20%
1 week-0.24%
Current month+1.38%
1 month+6.58%
3 months+8.62%
6 months+1.14%
Current year-4.59%
1 week 12.47
Extreme 12.47
13.03
1 month 11.24
Extreme 11.24
13.03
Current year 10.45
Extreme 10.45
14.09
1 year 10.45
Extreme 10.45
14.09
3 years 9.9
Extreme 9.9
16.65
5 years 8.69
Extreme 8.69
16.65
10 years 0
Extreme 0
18.52
Manager TitleAgeSince
Chief Executive Officer 62 2025-08-03
Director of Finance/CFO 51 2025-08-03
Chief Operating Officer - 2026-05-31
Director TitleAgeSince
Director/Board Member 71 2017-08-13
Chairman 78 2019-09-29
Director/Board Member 62 2020-03-01
Change 5-day change 1-year change 3-year change Capi.($)
-2.20%-0.24% - - 6.13B
-0.25%+2.58%-13.82%+10.06% 198B
-1.94%+1.90%-0.99%+13.22% 120B
-0.76%+1.51%+3.62%+74.44% 60.51B
-2.52%-7.69%+27.30%+56.41% 53.64B
+0.01%+3.10%-5.81%-31.45% 51.1B
+0.38%-1.38%+10.47%-14.93% 33.92B
-3.92%-8.43% - - 29.75B
+0.28%+2.20%+43.59%-8.77% 24.83B
-0.68%-4.25%-6.59%+24.25% 23.01B
Average -1.16%-0.63%+7.22%+15.40% 66.14B
Weighted average by Cap. -0.98%+0.86%-0.32%+16.52%

Financials

2026 *2027 *
Net sales 2.56B 2.19B 2.04B 1.87B 3.52B 245B 3.59B 24.23B 9.44B 123B 9.6B 9.39B 406B 2.73B 2.34B 2.18B 2B 3.76B 261B 3.84B 25.89B 10.09B 131B 10.26B 10.03B 434B
Net income 248M 213M 198M 182M 342M 23.75B 349M 2.35B 917M 11.9B 932M 912M 39.41B 360M 308M 288M 264M 496M 34.45B 506M 3.41B 1.33B 17.27B 1.35B 1.32B 57.16B
Net Debt 1.35B 1.15B 1.08B 987M 1.85B 129B 1.89B 12.76B 4.97B 64.54B 5.05B 4.94B 214B 1.15B 982M 917M 841M 1.58B 110B 1.61B 10.87B 4.24B 55.02B 4.31B 4.21B 182B
Logo Convatec Group PLC
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
10,000
Date Price Change Volume
26-08-20 US$12.47 -2.20% 7,540
26-08-19 US$12.75 -2.14% 9,023
26-08-18 US$13.03 +3.09% 2,927
26-08-17 US$12.64 +0.08% 13,989
26-08-14 US$12.63 +1.04% 171,022
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
3.078USD
Average target price
4.033USD
Spread / Average Target
+31.05%

Quarterly revenue - Rate of surprise